Jerome Ritz Selected Research

Hematopoietic Stem Cell Transplantation

11/2022	A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease.
1/2020	Maturation and Phenotypic Heterogeneity of Human CD4+ Regulatory T Cells From Birth to Adulthood and After Allogeneic Stem Cell Transplantation.
1/2020	Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease.
1/2020	Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect.
10/2019	Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4+ and CD8+ T effector memory cells and increase of T regulatory cells.
1/2019	Clinical Metabolomics Identifies Blood Serum Branched Chain Amino Acids as Potential Predictive Biomarkers for Chronic Graft vs. Host Disease.
1/2019	Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
11/2018	Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation.
1/2018	Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results.
1/2017	Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerome Ritz Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 05/2002
47	Bronchiolitis Obliterans Syndrome 11/2022 - 04/2004
33	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2022 - 09/2002
29	Leukemia 12/2022 - 06/2002
20	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2003
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2006
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2014 - 05/2002
10	Multiple Myeloma 12/2020 - 06/2002
9	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2022 - 10/2006
8	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 12/2005
5	Disease Progression 01/2021 - 03/2011
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 06/2005
4	Lymphoma (Lymphomas) 01/2022 - 12/2016
4	Infections 01/2022 - 04/2012
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020 - 04/2004
4	Melanoma (Melanoma, Malignant) 01/2018 - 05/2002
3	Bronchiolitis Obliterans 12/2022 - 02/2012
3	Viremia 01/2022 - 05/2010
3	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 05/2017
3	Virus Diseases (Viral Diseases) 01/2021 - 01/2020
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 06/2002
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 01/2016
2	Injection Site Reaction 12/2022 - 11/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2020
2	Anemia 11/2021 - 01/2021
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2016
2	COVID-19 01/2021 - 07/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 05/2002
2	Fibrosis (Cirrhosis) 01/2017 - 02/2012
2	Myeloid Leukemia (Leukemia, Myelocytic) 03/2015 - 02/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2009 - 08/2008
2	Blast Crisis (Blast Phase) 08/2004 - 12/2002
1	Immune System Diseases (Immune Disorders) 01/2022
1	Chronic Renal Insufficiency 01/2021

Drug/Important Bio-Agent (IBA)

20	AntigensIBA 01/2021 - 05/2002
15	Interleukin-2 (IL2)IBA 11/2022 - 02/2002
12	VaccinesIBA 12/2022 - 05/2002
11	AntibodiesIBA 01/2018 - 05/2002
10	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2004
8	Tacrolimus (Prograf)FDA LinkGeneric 12/2022 - 10/2009
8	Minor Histocompatibility AntigensIBA 03/2010 - 01/2003
7	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2022 - 05/2002
6	Methotrexate (Mexate)FDA LinkGeneric 12/2022 - 10/2009
6	SteroidsIBA 11/2022 - 08/2004
5	CytokinesIBA 01/2022 - 02/2002
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2013
5	Bortezomib (Velcade)FDA Link 01/2018 - 10/2009
5	Peptides (Polypeptides)IBA 01/2017 - 01/2004
5	Complementary DNA (cDNA)IBA 03/2015 - 05/2002
4	Sirolimus (Rapamycin)FDA Link 01/2020 - 01/2018
4	Biological ProductsIBA 11/2017 - 06/2005
4	Immunoglobulins (Immunoglobulin)IBA 06/2014 - 02/2010
4	Rituximab (Mabthera)FDA Link 06/2013 - 06/2002
3	Cell-Free Nucleic AcidsIBA 01/2022 - 07/2020
3	InterferonsIBA 12/2020 - 06/2015
3	Pharmaceutical PreparationsIBA 12/2020 - 11/2016
3	LigandsIBA 01/2020 - 06/2015
3	EpitopesIBA 01/2019 - 01/2004
3	Immune Checkpoint InhibitorsIBA 01/2018 - 07/2016
3	Monoclonal AntibodiesIBA 01/2017 - 10/2002
3	Interferon-gamma (Interferon, gamma)IBA 06/2015 - 02/2002
3	B-Cell Activating FactorIBA 05/2014 - 10/2007
2	pembrolizumabIBA 01/2022 - 01/2019
2	Interleukin-22 (IL-22)IBA 11/2021 - 01/2021
2	IpilimumabIBA 10/2021 - 07/2016
2	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2018
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 12/2017
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2019
2	Thomsen-Friedenreich antibodiesIBA 11/2018 - 12/2017
2	GlobulinsIBA 11/2018 - 12/2017
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2018 - 05/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 02/2012
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018 - 07/2006
2	Programmed Cell Death 1 ReceptorIBA 01/2018 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 05/2010
2	Busulfan (Busulfex)FDA Link 11/2015 - 06/2010
2	fludarabineIBA 11/2015 - 06/2010
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2014 - 11/2009
2	Alemtuzumab (Campath)FDA Link 06/2013 - 05/2013
2	Nucleic AcidsIBA 04/2011 - 02/2009
2	Staphylococcal Protein A (Protein A)IBA 02/2009 - 01/2008
2	OligonucleotidesIBA 05/2007 - 01/2006
2	AutoantibodiesIBA 03/2007 - 10/2002
2	Imatinib Mesylate (Gleevec)FDA Link 08/2004 - 01/2004
1	ChromatinIBA 12/2022
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 12/2022
1	CalcineurinIBA 10/2022
1	RNA (Ribonucleic Acid)IBA 01/2022

Therapy/Procedure

57	Hematopoietic Stem Cell Transplantation 11/2022 - 10/2002
37	Therapeutics 01/2022 - 02/2002
21	Transplantation 10/2021 - 06/2002
17	Stem Cell Transplantation 01/2022 - 09/2002
13	Cell Transplantation 10/2022 - 10/2006
11	Immunotherapy 01/2022 - 06/2002
6	Drug Therapy (Chemotherapy) 01/2022 - 10/2006
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2016 - 07/2002
4	Homologous Transplantation 11/2020 - 08/2004
2	Aftercare (After-Treatment) 11/2021 - 02/2010
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2021 - 01/2018
1	Duration of Therapy 01/2021